Sylvain Baron
Stanford University
4 Papers
16 Citations
Sylvain Baron is an academic researcher from Stanford University. The author has contributed to research in topics: Cell & Cell cycle. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Unimpaired skin carcinogenesis in Desmoglein 3 knockout mice.
TL;DR: It is found that Dsg3 does not display a clear function as a tumor suppressor in these mouse skin cancer models, and it is shown that these cells display adhesion defects in vitro and compromised tumor growth in allograft assays, suggesting that DSG3 enables tumor formation in certain settings.
Estrogen and antiestrogen-dependent regulation of breast cancer cell proliferation in multicellular spheroids : Influence of cell microenvironment
Isabelle Truchet,Suzanne Jozan,Sylvain Baron,C. Frongia,P. Balaguer,H. Richard-Foy,Annie Valette +6 more
TL;DR: Results indicate that theMulticellular tumor spheroids model, an in vitro 3-D model that simulates malignant-cell contacts within a tumor, is more relevant to an in vivo situation than monolayer cultures.
16
Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer
Rachel L. Dusek,Jamie L. Bascom,Hannes Vogel,Sylvain Baron,Alexander D. Borowsky,Mina J. Bissell,Laura D. Attardi +6 more
TL;DR: Interestingly, although altering desmosomes through genetic inactivation of Perp does not dramatically impair mammary gland ductal development, Perp loss affects Mammary epithelial homeostasis by causing the accumulation of inflammatory cells around mature mammary epithelium.
ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells
Iman Aftab Khan,Byong Hoon Yoo,Olivier Masson,Sylvain Baron,Dale Corkery,Graham Dellaire,Laura D. Attardi,Kirill V. Rosen +7 more
TL;DR: A novel mechanism of ErBB2-mediated mechanism of anoikis resistance of ErbB2 -overproducing breast epithelial cells is identified, which allows such cells to grow without adhesion to the ECM and is driven by Erb B2-induced activation of Mek, subsequent EGFR upregulation and further EGFR-dependent Perp loss.